Literature DB >> 15172973

Association of Foxp3 regulatory gene expression with graft-versus-host disease.

Yuji Miura1, Christopher J Thoburn, Emilie C Bright, Michele L Phelps, Tahiro Shin, Elizabeth C Matsui, William H Matsui, Sally Arai, Ephraim J Fuchs, Georgia B Vogelsang, Richard J Jones, Allan D Hess.   

Abstract

Graft-versus-host disease (GVHD) is characterized by an impairment of mechanisms that underlie the development of immunologic tolerance. Although the cytokine storm associated with GVHD leads to expression of cell surface markers on both effector and regulatory T cells, regulatory CD4+ T cells that play an instrumental role in the maintenance of tolerance appear to uniquely express the Foxp3 transcriptional repressor. Foxp3 mRNA expression was significantly decreased in peripheral blood mononuclear cells from patients with either allogeneic GVHD or autologous GVHD compared with patients without GVHD. Expression of Foxp3 negatively correlated with the severity of GVHD but positively correlated with recent thymic emigrants. The results suggest that defective thymic function contributes to the impaired reconstitution of immune regulatory mechanisms following transplantation. The decrease in regulatory mechanisms after transplantation appears to provide an environment permissive to the development of GVHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172973     DOI: 10.1182/blood-2004-03-1040

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  106 in total

1.  Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation.

Authors:  Alain M Ngoma; Kazuhiko Ikeda; Yuko Hashimoto; Kazuhiro Mochizuki; Hiroshi Takahashi; Hideki Sano; Hayato Matsumoto; Hideyoshi Noji; Syunnichi Saito; Atsushi Kikuta; Kazuei Ogawa; Mikio Ohtsuka; Masafumi Abe; Kenneth E Nollet; Hitoshi Ohto
Journal:  Int J Hematol       Date:  2011-12-14       Impact factor: 2.490

2.  Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Authors:  Hemalatha Rangarajan; Maryam Yassai; Hariharan Subramanian; Richard Komorowski; Megan Whitaker; Jack Gorski; William R Drobyski
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

Review 3.  Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.

Authors:  Doreen Haase; Mireille Starke; Kia Joo Puan; Tuck Siong Lai; Olaf Rotzschke
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

5.  Effects of allogeneic hematopoietic stem cell transplantation plus thymus transplantation on malignant tumors: comparison between fetal, newborn, and adult mice.

Authors:  Yuming Zhang; Naoki Hosaka; Yunze Cui; Ming Shi; Susumu Ikehara
Journal:  Stem Cells Dev       Date:  2010-09-13       Impact factor: 3.272

6.  CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

Authors:  Amy J Beres; Dipica Haribhai; Alexandra C Chadwick; Patrick J Gonyo; Calvin B Williams; William R Drobyski
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

7.  Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD.

Authors:  A H Elmaagacli; M Ditschkowski; N K Steckel; T Gromke; H Ottinger; U Hillen; H A Baba; R Trenschel; D W Beelen; M Koldehoff
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

8.  Emergent autoimmunity in graft-versus-host disease.

Authors:  Elizabeth Tivol; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

Authors:  Stephan Mielke; Katayoun Rezvani; Bipin N Savani; Raquel Nunes; Agnes S M Yong; John Schindler; Roger Kurlander; Victor Ghetie; Elizabeth J Read; Scott R Solomon; Ellen S Vitetta; A John Barrett
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

Review 10.  Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?

Authors:  Joseph Pidala; Claudio Anasetti
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.